✅ Yes, the content seems to be true and authentic, as reported by several sources.

These, include:

1. https://aspe.hhs.gov/sites/default/files/documents/127bd5b3347b34be31ac5c6b5ed30e6a/medicare-coverage-anti-obesity-meds.pdf - (Trust Score 9/10)

- The CMS has proposed to reinterpret the statutory exclusion of agents when for weight loss to allow Medicare Part D coverage of anti-obesity medications.

2. https://www.kff.org/policy-watch/proposed-coverage-of-anti-obesity-drugs-in-medicare-and-medicaid-would-expand-access-to-millions-of-people-with-obesity/ - (Trust Score 8/10)

- The Biden administration has proposed to allow Medicare and require Medicaid to cover drugs used to treat obesity by reinterpreting the statutory language.

3. https://www.michiganmedicine.org/health-lab/heart-question-who-can-get-medicare-covered-weight-loss-medicine - (Trust Score 7/10)

- Wegovy (semaglutide) now has Medicare approval for coverage among people with obesity and cardiovascular disease but no diabetes.